Detection of urinary prostate specific antigen by a lateral flow biosensor predicting repeat prostate biopsy outcome

Approaches to urinary detection of prostate cancer

(2019) Jillian N. Eskra et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Direct vs Mediated Coupling of Antibodies to Gold Nanoparticles: The Case of Salivary Cortisol Detection by Lateral Flow Immunoassay

(2019) Fabio Di Nardo et al.   ACS Applied Materials & Interfaces

A versatile and sensitive lateral flow immunoassay for the rapid diagnosis of visceral leishmaniasis

(2018) Laura Anfossi et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening for Prostate Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

(2018) Kari A O Tikkinen et al.   BMJ-British Medical Journal

Silver and gold nanoparticles as multi-chromatic lateral flow assay probes for the detection of food allergens

(2018) Laura Anfossi et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2017) Nicolas Mottet et al.   EUROPEAN UROLOGY

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL

(2016) Stéphane Bolduc et al.   CUAJ-Canadian Urological Association Journal

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

(2015) Richard J. Bryant et al.   JNCI-Journal of the National Cancer Institute

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

(2015) Henrik Grönberg et al.   LANCET ONCOLOGY

Addressing the need for repeat prostate biopsy: new technology and approaches

(2015) Michael L. Blute et al.   Nature Reviews Urology

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

(2015) Richard J. Bryant et al.   JNCI-Journal of the National Cancer Institute

Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?

(2014) John T. Wei et al.   JOURNAL OF CLINICAL ONCOLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

The growing evidence supporting mid-life PSA testing

(2013) Daniel Reinhardt et al.   Nature Reviews Urology

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: A Performance Comparison in a Contemporary Screened Cohort

(2010) Vítor Cavadas et al.   EUROPEAN UROLOGY

Screening for Prostate Cancer

(2009) O. W. Brawley et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE